Design and Preclinical Evaluation of 18F-Labeled Phenoxyalkylguanidines as Novel Norepinephrine Transporter Radiotracers for Myocardial and Tumor Imaging
Journal of Medicinal Chemistry · 13.08.2026 · 69 (15) · 19525-19539
DOI: 10.1021/acs.jmedchem.6c02005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.08.2026. Verfasst von Yueqi Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Clinical Nuclear Medicine Research Lab, West China Hospital, Sichuan University, Chengdu, Sichuan610041, China. Hauptthemen laut MEDLINE: Norepinephrine Plasma Membrane Transport Proteins, Fluorine Radioisotopes, Guanidines, Radiopharmaceuticals. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Nuclear Power Institute of China, National Natural Science Foundation of China, Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
The norepinephrine transporter (NET) is a key target for PET imaging of sympathetic nerves and neuroendocrine tumors. Herein, we developed a series of novel aryl 18F-labeled phenoxyalkylguanidine PET tracers with optimized alkoxy chains to improve NET-binding affinity, metabolic stability, and imaging performance. The tracers were readily synthesized by photocatalyzed 18F-fluorination. The lead compound, [18F] o FPhOEG, exhibited high radiochemical conversion (82.8%), favorable lipophilicity (logD = −0.39), and potent NET affinity (IC50 = 0.097 μM). In vivo studies demonstrated high and sustained target uptake (myocardial SUVmax = 8.95 in rats; tumor SUVmax = 23.35 in mice) and rapid hepatic clearance, resulting in heart-to-liver and tumor-to-liver ratios approximately 3-fold higher than those of the clinically used [18F] m FBG. Moreover, [18F] o FPhOEG was successfully produced on a commercial automated synthesizer from a readily available precursor, highlighting its promise for clinical translation in cardiac and oncological PET imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine and Clinical Nuclear Medicine Research Lab, West China Hospital, Sichuan University, Chengdu, Sichuan610041, China.
- Sichuan Provincial Engineering Research Center of Radiopharmaceutical Clinical Translation, Sichuan University, Chengdu, Sichuan610065, China.
- Sichuan Provincial Health Commission Key Laboratory of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan610041, China.
ORCID-Profile: Wei Chen
Förderung
- Nuclear Power Institute of China
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
- Sichuan University
- Fundamental Research Funds for the Central Universities
- West China Hospital, Sichuan University
- National Science and Technology Major Project
- ?Qimingxing? Research Fund for young talents
Zitieren
APA
Wang, Y., Hu, M., Pan, L., Xie, Y., Zou, Y., Zheng, C., Lu, K., Cao, Y., Li, M., Yin, H., Du, J., & Chen, W. (2026). Design and Preclinical Evaluation of 18F-Labeled Phenoxyalkylguanidines as Novel Norepinephrine Transporter Radiotracers for Myocardial and Tumor Imaging. Journal of Medicinal Chemistry, 69(15), 19525-19539. https://doi.org/10.1021/acs.jmedchem.6c02005
Vancouver
Wang Y, Hu M, Pan L, Xie Y, Zou Y, Zheng C, et al. Design and Preclinical Evaluation of 18F-Labeled Phenoxyalkylguanidines as Novel Norepinephrine Transporter Radiotracers for Myocardial and Tumor Imaging. Journal of Medicinal Chemistry. 2026;69(15):19525-19539. doi:10.1021/acs.jmedchem.6c02005
BibTeX
@article{Wang2026,
author = {Wang, Yueqi and Hu, Mingxing and Pan, Lili and Xie, Yang and Zou, Yuheng and Zheng, Cheng and Lu, Kai and Cao, Yarong and Li, Mufeng and Yin, Honghai and Du, Jiao and Chen, Wei},
title = {Design and Preclinical Evaluation of 18F-Labeled Phenoxyalkylguanidines as Novel Norepinephrine Transporter Radiotracers for Myocardial and Tumor Imaging},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {15},
pages = {19525--19539},
doi = {10.1021/acs.jmedchem.6c02005}
}
EUVIMED